Breathlessness / dyspnoea — approach
Approach · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Classify by tempo: acute (hrs–days, dangerous shortlist) vs chronic (>4–8 wk; usually asthma, COPD, ILD, heart failure or obesity/deconditioning).
Assessment
Investigations
- Acute: ABG, ECG, CXR, FBC/U&E/CRP, BNP; D-dimer/CTPA (PE); peak flow; lung US/echo
- Chronic tiered: spirometry pre/post BD, oximetry at rest + during 200 m ambulation, ECG, CXR, NT-proBNP
- 3 most informative for unexplained: FEV₁, NT-proBNP, % emphysema on CT; echo (HF/PH), HRCT (ILD); CPET if still unexplained
Management
- Sit up; titrate O₂ (94–98%, or 88–92% if COPD risk); IV access, monitor
- Urgent clues: HR >120, RR >30, SpO₂ <90%, accessory muscles, can’t speak full sentences, stridor, asymmetric breath sounds, cyanosis
- Treat the cause (nebs/adrenaline/decompression as indicated)
Disposition
Orthopnoea/PND → heart failure; chest tightness → asthma; air hunger → HF/PE; effort → COPD/neuromuscular. A known chronic lung/heart disease does not guarantee it is the current cause.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.